Role of induction chemotherapy in resectable N2 non-small cell lung cancer.
de Marinis
Filippo
F
Department of Lung Diseases, San Camillo-Forlanini Hospitals, Rome, Italy. demarinis.filippo@virgilio.it
Tedesco
Beatrice
B
Treggiari
Stefano
S
De Santis
Stefano
S
Cipri
Antonio
A
Belli
Raffaele
R
Condò
Silvia
S
Ariganello
Ottavio
O
Di Molfetta
Michele
M
Migliorino
Maria Rita
MR
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000532:radiotherapy; D002945:Cisplatin / Q000008:administration & dosage; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D020360:Neoadjuvant Therapy; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic; D043823:Taxoids / Q000008:administration & dosage; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000077235:Vinorelbine; D000093542:Gemcitabine
D000970:Antineoplastic Agents; D043823:Taxoids; D003841:Deoxycytidine; D014747:Vinblastine; D016190:Carboplatin; D002945:Cisplatin; D000077235:Vinorelbine; D000093542:Gemcitabine